Close
4

Athena Athena

X

Find Thiabendazole manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

Looking for 148-79-8 / Thiabendazole API manufacturers, exporters & distributors?

Thiabendazole manufacturers, exporters & distributors 1

60

PharmaCompass offers a list of Thiabendazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Thiabendazole manufacturer or Thiabendazole supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Thiabendazole manufacturer or Thiabendazole supplier.

PharmaCompass also assists you with knowing the Thiabendazole API Price utilized in the formulation of products. Thiabendazole API Price is not always fixed or binding as the Thiabendazole Price is obtained through a variety of data sources. The Thiabendazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Thiabendazole

Synonyms

148-79-8, Tiabendazole, Mintezol, 2-(4-thiazolyl)benzimidazole, Omnizole, Thiabenzole

Cas Number

148-79-8

Unique Ingredient Identifier (UNII)

N1Q45E87DT

About Thiabendazole

2-Substituted benzimidazole first introduced in 1962. It is active against a variety of nematodes and is the drug of choice for STRONGYLOIDIASIS. It has CENTRAL NERVOUS SYSTEM side effects and hepatototoxic potential. (From Smith and Reynard, Textbook of Pharmacology, 1992, p919)

MolPort-001-002-054 Manufacturers

A MolPort-001-002-054 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MolPort-001-002-054, including repackagers and relabelers. The FDA regulates MolPort-001-002-054 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MolPort-001-002-054 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of MolPort-001-002-054 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

MolPort-001-002-054 Suppliers

A MolPort-001-002-054 supplier is an individual or a company that provides MolPort-001-002-054 active pharmaceutical ingredient (API) or MolPort-001-002-054 finished formulations upon request. The MolPort-001-002-054 suppliers may include MolPort-001-002-054 API manufacturers, exporters, distributors and traders.

click here to find a list of MolPort-001-002-054 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

MolPort-001-002-054 USDMF

A MolPort-001-002-054 DMF (Drug Master File) is a document detailing the whole manufacturing process of MolPort-001-002-054 active pharmaceutical ingredient (API) in detail. Different forms of MolPort-001-002-054 DMFs exist exist since differing nations have different regulations, such as MolPort-001-002-054 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A MolPort-001-002-054 DMF submitted to regulatory agencies in the US is known as a USDMF. MolPort-001-002-054 USDMF includes data on MolPort-001-002-054's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MolPort-001-002-054 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of MolPort-001-002-054 suppliers with USDMF on PharmaCompass.

MolPort-001-002-054 WC

A MolPort-001-002-054 written confirmation (MolPort-001-002-054 WC) is an official document issued by a regulatory agency to a MolPort-001-002-054 manufacturer, verifying that the manufacturing facility of a MolPort-001-002-054 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting MolPort-001-002-054 APIs or MolPort-001-002-054 finished pharmaceutical products to another nation, regulatory agencies frequently require a MolPort-001-002-054 WC (written confirmation) as part of the regulatory process.

click here to find a list of MolPort-001-002-054 suppliers with Written Confirmation (WC) on PharmaCompass.

MolPort-001-002-054 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MolPort-001-002-054 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for MolPort-001-002-054 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture MolPort-001-002-054 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain MolPort-001-002-054 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MolPort-001-002-054 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of MolPort-001-002-054 suppliers with NDC on PharmaCompass.

MolPort-001-002-054 GMP

MolPort-001-002-054 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of MolPort-001-002-054 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right MolPort-001-002-054 GMP manufacturer or MolPort-001-002-054 GMP API supplier for your needs.

MolPort-001-002-054 CoA

A MolPort-001-002-054 CoA (Certificate of Analysis) is a formal document that attests to MolPort-001-002-054's compliance with MolPort-001-002-054 specifications and serves as a tool for batch-level quality control.

MolPort-001-002-054 CoA mostly includes findings from lab analyses of a specific batch. For each MolPort-001-002-054 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

MolPort-001-002-054 may be tested according to a variety of international standards, such as European Pharmacopoeia (MolPort-001-002-054 EP), MolPort-001-002-054 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MolPort-001-002-054 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY